← Browse by Condition
Medical Condition

intermediate trophoblastic tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06941766 Phase 1, Phase 2
Recruiting

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

Enrollment
20 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →